Home Health Care News June 5, 2024
As UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) work on a divestment strategy that will satisfy regulators, a lot hangs in the balance.
For one, UnitedHealth Group and Optum’s deal for the home health and hospice provider Amedisys is one of the largest deals in the industry’s history, only trailing Optum’s deal for Amedisys’ peer, LHC Group, last year. The former deal is worth $3.3 billion and still pending, while the other was worth $5.4 billion and is finalized.
Getting the deal done is important to both parties. UnitedHealth Group is banking on home-based health care for its value-based care strategy, but is under significant and widespread antitrust scrutiny. Amedisys, on the other hand, has a good deal in...
Today's Sponsors
Today's Sponsor